In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 1, 2008, Pages 206-208

  Walkty, Andrew ^a   Decorby, Melanie ^b   Nichol, Kim ^a   Karlowsky, James A ^a   Hoban, Daryl J ^a,b   Zhanel, George G ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antimicrobial resistance; Cefepime; Susceptibility

Indexed keywords

CEFEPIME; CEFTOBIPROLE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CONTROLLED STUDY; CROSS RESISTANCE; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CANADA; CEPHALOSPORINS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 45749156804     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn140     Document Type: Letter

References (6)

1. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
2. Pillar CM, Aranza MK, Shah D et al. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin. J Antimicrob Chemother 2008; 61: 595-602.
3. Queenan AM, Shang W, Kania M et al. Interactions of ceftobiprole with β-lactamases from molecular classes A to D. Antimicrob Agents Chemother 2007; 51: 3089-95.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
5. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
6. Hebeisen P, Heinze-Krauss I, Angehm P et al. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob Agents Chemother 2001; 45: 825-36.